• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS XPRECIA STRIDE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS XPRECIA STRIDE Back to Search Results
Catalog Number 10714595
Device Problem Non Reproducible Results (4029)
Patient Problem Pulmonary Embolism (1498)
Event Date 04/21/2020
Event Type  Injury  
Manufacturer Narrative
This event, escalated to siemens is considered 'off-label use' because the product was sold to a home user and the system is not cleared for sale for patient at-home testing.The instrument has been returned to the distributor.Siemens has requested the instrument and strips to be returned for investigation.When the distributor was asked, if they were aware that this device is not for home use, the distributor stated that in fiscal year 2019, two systems were sold to them.They promoted the system on their website.After it was discovered that the system was sold to a private person, the promotion was removed from the website to prevent this in the future.The cause of this event is unknown.
 
Event Description
A customer purchased an xprecia stride device on (b)(6) 2019 from an online distributor for home use.The xprecia stride system is not currently approved for home use.The distributor is identified as the initiator of the complaint to siemens.The patient takes coumadin regularly and should always be between 2.5 - 3.5 pt inr.First thing in the morning, the patient spit up blood.The patient already planned on going to the hospital due to spitting blood, but wanted to test his pt inr with xprecia stride anyway.The xprecia pt inr result was higher than the pt inr non-siemens hospital lab device.The patient was later diagnosed with a pulmonary embolism at the hospital.
 
Manufacturer Narrative
Siemens received the customer's decontaminated xprecia stride (sn (b)(6)) along with pt/inr strips lot # 401635 from the customer.There was no physical damage observed.Good agreement was observed between the customer's analyzer and siemens in-house analyzer (s/n (b)(6)) with retains of the same lot.Both lqc levels were in the specified ranges for pt/inr strips.The customer's analyzer was not statistically different from siemens in-house analyzer.The data files were downloaded and there were several non assay errors found during the customer's usage including: test strip port protective cap missing.Test strip inserted early.Test strip or lqc vial not valid.Apply sample timeout.Early test strip ejection.Test strip port protective cap removed.The quality control results confirm that the customer's analyzer and the pt/inr strips are working as intended.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XPRECIA STRIDE
Type of Device
XPRECIA STRIDE
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS
511 benedict avenue
tarrytown, ny
MDR Report Key10242693
MDR Text Key198166216
Report Number3002637618-2020-00030
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
PMA/PMN Number
K151964
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 08/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue Number10714595
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 06/16/2020
Initial Date FDA Received07/07/2020
Supplement Dates Manufacturer Received08/05/2020
Supplement Dates FDA Received08/06/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age40 YR
-
-